https://www.businesswire.com/news/home/20260520408301/en/Acuitas-Therapeutics-Highlights-In-Vivo-CAR-T-Cell-Engineering-and-Ionizable-Lipid-Quality-Attributes-at-the-2026-ASGCT-Annual-Meeting
Acuitas Therapeutics Highlights In Vivo CAR T Cell Engineering and Ionizable Lipid Quality...
Targeted extended circulation LNP achieved complete B cell depletion in nonhuman primates through highly specific in vivo CD8+ T cell engineering
car t cellacuitas therapeuticsin vivohighlightsengineering